Erik Schaefer is a Co-founder, CEO & CSO at AssayQuant Technologies, Inc. based in Hopkinton, Massachusetts, United States, North America. I am an R&D and Business Leader with >25 years of experience in the life science research tool industry, building and inspiring high-performing teams to deliver results with technology innovation, new product development (over 1000 products), and commercial success. I have directed the design, development, integration, and commercialization of new technologies, working across disciplines of engineering, molecular and cellular biology, signal transduction, chemistry, protein biochemistry, sample preparation, and assay development (antibody, enzyme, molecular, or cell-based platforms) to accelerate basic research and enable drug discovery or diagnostics. Critical to this path has been a focus on pioneering the development of novel reagents and assays that enhance our understanding of the complex biology in cells and tissues and across disease areas, including cancer, inflammation, neurodegeneration, cardiovascular disease, and diabetes. I have a deep understanding of cellular signaling pathways and the critical roles of protein kinases and phosphatases in directing cellular phenotypes in normal and disease states.
Current Position: Co-founder, CEO & CSO
Company: AssayQuant Technologies, Inc.
Location: Hopkinton, Massachusetts, United States, North America
Social: Professional profiles available
Network: Extensive professional connections